NMDA RECEPTOR ANTIBODY, SERUM

image not found

NABL Cap Accredited    
The NMDA Receptor Antibody test detects antibodies directed against NMDA (N-methyl-D-aspartate) receptors in the brain, useful in diagnosing autoimmune encephalitis. This condition can cause symptoms such as seizures, memory problems, behavior changes, and psychiatric disturbances. Early diagnosis is critical for appropriate immunotherapy and improved neurological outcomes. Metropolis Healthcare offers highly sensitive and specific antibody testing using advanced immunoassay methods to support accurate identification and timely clinical management
 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 7,950.00

Sample Type: SERUM

Fasting Not Required


Notes: N0028

Frequently Asked Questions (FAQ's):

What does the NMDA Receptor Antibody test include?
This test measures serum antibodies against NMDA receptors to help diagnose autoimmune encephalitis, processed with precision at Metropolis Healthcare.

How does Metropolis Healthcare perform the NMDA antibody testing?
Metropolis Healthcare uses advanced cell-based assays and high-sensitivity immunoassay platforms to ensure reliable detection of NMDA receptor antibodies.

Who should take the NMDA Receptor Antibody test?
Patients with unexplained seizures, altered behavior, memory loss, psychiatric symptoms, or suspected autoimmune encephalitis should undergo this test at Metropolis Healthcare.

Why is the NMDA Receptor Antibody test important?
It supports early diagnosis and treatment planning for autoimmune encephalitis, with expert neurological testing support at Metropolis Healthcare.

Is fasting required before this test?
No fasting is required, and Metropolis Healthcare provides convenient and safe blood sample collection.

How long does it take to receive results from Metropolis Healthcare?
Results are typically available within a few working days depending on laboratory workflow.

Can medications affect NMDA antibody levels?
Certain immunosuppressant drugs may influence results; Metropolis Healthcare recommends informing your doctor about ongoing treatments.

Is this test useful for monitoring recovery?
Yes, changes in antibody levels may assist in assessing response to therapy and risk of relapse, supported by reliable follow-up testing at Metropolis Healthcare

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab